Current lead natural products for the chemotherapy of human immunodeficiency virus (HIV) infection.
about
Anti-viral activity of red microalgal polysaccharides against retrovirusesCurcumin, a diferuloylmethane, attenuates cyclosporine-induced renal dysfunction and oxidative stress in rat kidneys.Seco-pregnane steroids target the subgenomic RNA of alphavirus-like RNA virusesA new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivoConcise Review: CXCR4/CXCL12 Signaling in Immature Hematopoiesis--Lessons From Pharmacological and Genetic ModelsTriple combination MPT vaginal microbicide using curcumin and efavirenz loaded lactoferrin nanoparticlesSulfated polysaccharides in marine sponges: extraction methods and anti-HIV activityThe Effect of Root, Shoot and Seed Extracts of The Iranian Thymus L. (Family: Lamiaceae) Species on HIV-1 Replication and CD4 ExpressionQ28831186A review of current intravaginal drug delivery approaches employed for the prophylaxis of HIV/AIDS and prevention of sexually transmitted infectionsWas it there all the time?Inhibition of HIV-1 entry by extracts derived from traditional Chinese medicinal herbal plantsImproving physical properties via C-H oxidation: chemical and enzymatic approachesA small-molecule antagonist of virion assembly.Potential anti-HIV agents from marine resources: an overview.Scutellaria baicalensis, the golden herb from the garden of Chinese medicinal plantsNovel antiviral agents: a medicinal plant perspective.Virologic and immunologic outcome of treatment of HIV infection with a herbal concoction, α-Zam, among clients seeking herbal remedy in NigeriaInitial therapy for human immunodeficiency virus: broadening the options.Discovering natural product modulators to overcome multidrug resistance in cancer chemotherapy.The next generation of HIV/AIDS drugs: novel and developmental antiHIV drugs and targets.Constructing an integrated genetic and epigenetic cellular network for whole cellular mechanism using high-throughput next-generation sequencing data.Marine natural products: a way to new drugsDatabase of traditional Chinese medicine and its application to studies of mechanism and to prescription validationThe discovery of a class of novel HIV-1 maturation inhibitors and their potential in the therapy of HIV.Effects of flavocoxid, a dual inhibitor of COX and 5-lipoxygenase enzymes, on benign prostatic hyperplasia.Anti-HSV-2 activity of Terminalia chebula Retz extract and its constituents, chebulagic and chebulinic acids.Preclinical development of the green tea catechin, epigallocatechin gallate, as an HIV-1 therapy.Ingenol Protects Human T Cells From HIV-1 Infection.Venom Components of Iranian Scorpion Hemiscorpius lepturus Inhibit the Growth and Replication of Human Immunodeficiency Virus 1 (HIV-1).Flavocoxid, a dual inhibitor of cyclooxygenase and 5-lipoxygenase, blunts pro-inflammatory phenotype activation in endotoxin-stimulated macrophages.Post-translational import of protein into the endoplasmic reticulum of a trypanosome: an in vitro system for discovery of anti-trypanosomal chemical entities.NMR as an effective tool for the structure determination of lasso peptides.Mode of inhibition of HIV-1 reverse transcriptase by polyacetylenetriol, a novel inhibitor of RNA- and DNA-directed DNA polymerases.Lectins with anti-HIV activity: a review.Marine polysaccharides from algae with potential biomedical applications.Proteins, peptides, polysaccharides, and nucleotides with inhibitory activity on human immunodeficiency virus and its enzymes.Synthesis and biological evaluation of N-arylated-lactam-type iminosugars as potential immunosuppressive agents.Electrochemical Alcohol Oxidation Mediated by TEMPO-like Nitroxyl Radicals.The Molecular Basis of Toxins' Interactions with Intracellular Signaling via Discrete Portals.
P2860
Q24796246-F20A199B-45B8-45DA-BB05-C8B62CD96CCFQ24813812-511A4E60-6871-4781-B62A-C37F08EA1D1BQ27478419-29D002B6-877F-4A41-8FB8-FAD38BA953CFQ27490484-A1114E6D-51DF-419A-9D2A-75CC889D8F2BQ28080830-59912A9B-EC36-4906-B039-BC3CBFF0E37FQ28393885-60458B1E-7AA6-4C0E-AAAF-B08F0DB059D4Q28742770-51C5EFFB-D363-4B2C-A14C-5CC0A951C380Q28829943-50A4C2E1-5F32-4271-AEED-B307DE139F5DQ28831186-09809EEE-58A6-4850-B52F-7F263A81FCCBQ30369008-371B712E-6DE5-478E-BFE0-F41ED88BA293Q31144974-F273123A-688F-49F6-AA6D-2DC51E8D65ABQ33490833-4797E256-E903-4BF5-AE82-076E08D93BCFQ34481658-88642BD3-0EDE-4805-A789-13677B3F28C7Q34489215-82CDBA23-22D6-44FC-B5AA-63179F767D9CQ34576118-641414A2-CF84-4B6B-BC78-E6B6C75D15E8Q34679142-9E61BDD7-1B32-42D8-AD19-E3C8653AA881Q35197052-685C44A6-1AEA-43BA-AC2C-9987EFAC0D4FQ35556579-AC08B2D0-5385-4372-A21A-FC09CBF9AE72Q35759609-D7AAE601-17BC-462D-9157-10139B30379DQ35915497-C1C35621-40DD-4112-8031-6082D4E4E640Q35917148-E9A94159-525E-4AAF-A8DF-BCB6716E9E3CQ35929292-A47F8D2E-3645-4BE1-A773-87762325B907Q35944268-E6208AA6-A090-42AF-A257-15A6B8C3764FQ36054344-094E6B1B-C099-4C72-A86F-9A02598AC808Q36187060-8B38B01D-0E00-45AE-B216-2FF482BD5F61Q36252843-1FB3D701-092F-4B55-B9DC-EF7544D103F0Q36280339-25C98AD4-118E-43D3-BCCB-FF8396CC05E1Q37150917-A7B89D23-1A3B-4E88-81C9-725FEDC4FEDDQ37155721-609BB657-28D2-456C-98C4-A47542ECBB10Q37358795-438BA469-72E9-4A83-B881-DB7294505AF3Q37395300-18C80489-5DA8-4C8D-A24F-E3B103E30383Q37403820-27CD4413-B430-4AA7-89D6-7E071D2EC3F0Q37978834-24ED44DE-162A-4981-8002-FE6B1D80B4D4Q38291464-770D651B-46AA-49BF-ABC8-AD8191827A01Q38311332-8A827B5E-EF13-48D1-A602-DC2D2BB482A6Q38490891-7A9E41A7-27E2-4D9C-A258-7826F3B07B5CQ38593985-80628A86-636E-43C4-93C2-6E1CB74E19A3Q38697382-973BCFF1-94AA-4DB0-9341-E4761CB0971CQ39123484-3408C7DF-304A-4DE1-9874-9FFF55FE2104Q39181842-48400F8C-6D64-41C8-BF8E-A007EA1B151B
P2860
Current lead natural products for the chemotherapy of human immunodeficiency virus (HIV) infection.
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Current lead natural products ...... iciency virus (HIV) infection.
@ast
Current lead natural products ...... iciency virus (HIV) infection.
@en
type
label
Current lead natural products ...... iciency virus (HIV) infection.
@ast
Current lead natural products ...... iciency virus (HIV) infection.
@en
prefLabel
Current lead natural products ...... iciency virus (HIV) infection.
@ast
Current lead natural products ...... iciency virus (HIV) infection.
@en
P2860
P1476
Current lead natural products ...... iciency virus (HIV) infection.
@en
P2093
De Clercq E
P2860
P304
P356
10.1002/1098-1128(200009)20:5<323::AID-MED1>3.0.CO;2-A
P577
2000-09-01T00:00:00Z